Beta cell function in latent autoimmune diabetes in adults treated with linagliptin versus glimepiride: exploratory results from a 2 year double-blind randomised controlled study

被引：0
|
作者：
Johansen, O. [1 ]
Boehm, B. [2 ]
Grill, V. [3 ]
Torjesen, P. A. [4 ]
Bhattacharya, S. [5 ]
Patel, S. [6 ]
Wetzel, K. [5 ]
Woerle, H. -J. [7 ]
机构：
[1] Boehringer Ingelheim GmbH & Co KG, Asker, Norway
[2] Univ Ulm, D-89069 Ulm, Germany
[3] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway
[4] Aker Univ Hosp, Oslo, Norway
[5] Boehringer Ingelheim GmbH & Co KG, Biberach, Germany
[6] Boehringer Ingelheim GmbH & Co KG, Bracknell, Berks, England
[7] Boehringer Ingelheim KG, Ingelheim, Germany
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
148
引用
收藏
页码：S67 / S68
页数：2
相关论文
共 50 条
  • [1] C-Peptide Levels in Latent Autoimmune Diabetes in Adults Treated With Linagliptin Versus Glimepiride: Exploratory Results From a 2-Year Double-Blind, Randomized, Controlled Study
    Johansen, Odd Erik
    Boehm, Bernhard O.
    Grill, Valdemar
    Torjesen, Peter A.
    Bhattacharya, Sudipta
    Patel, Sanjay
    Wetzel, Kristiane
    Woerle, Hans-Juergen
    DIABETES CARE, 2014, 37 (01) : E11 - E12
  • [2] Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study
    Geert Jan Biessels
    Chloë Verhagen
    Jolien Janssen
    Esther van den Berg
    Gudrun Wallenstein
    Bernard Zinman
    Mark A. Espeland
    Odd Erik Johansen
    Diabetologia, 2021, 64 : 1235 - 1245
  • [3] Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study
    Biessels, Geert Jan
    Verhagen, Chloe
    Janssen, Jolien
    van den Berg, Esther
    Wallenstein, Gudrun
    Zinman, Bernard
    Espeland, Mark A.
    Johansen, Odd Erik
    DIABETOLOGIA, 2021, 64 (06) : 1235 - 1245
  • [4] 2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial
    Gallwitz, Baptist
    Rosenstock, Julio
    Rauch, Thomas
    Bhattacharya, Sudipta
    Patel, Sanjay
    von Eynatten, Maximilian
    Dugi, Klaus A.
    Woerle, Hans-Juergen
    LANCET, 2012, 380 (9840): : 475 - 483
  • [5] TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
    Burant, Charles F.
    Viswanathan, Prabhakar
    Marcinak, John
    Cao, Charlie
    Vakilynejad, Majid
    Xie, Benhuai
    Leifke, Eckhard
    LANCET, 2012, 379 (9824): : 1403 - 1411
  • [6] Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations:: results from a double-blind oral combination study with glimepiride
    Pfützner, A
    Schöndorf, T
    Seidel, D
    Winkler, K
    Matthaei, S
    Hamann, A
    Forst, T
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (01): : 20 - 25
  • [7] Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial
    Kapitza, Christoph
    Dahl, Kirsten
    Jacobsen, Jacob B.
    Axelsen, Mads B.
    Flint, Anne
    DIABETOLOGIA, 2017, 60 (08) : 1390 - 1399
  • [8] Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial
    Christoph Kapitza
    Kirsten Dahl
    Jacob B. Jacobsen
    Mads B. Axelsen
    Anne Flint
    Diabetologia, 2017, 60 : 1390 - 1399
  • [9] Initial combination of linagliptin and metformin in patients with type 2 diabetes: efficacy and safety in a randomised, double-blind 1-year extension study
    Haak, T.
    Meinicke, T.
    Jones, R.
    Weber, S.
    von Eynatten, M.
    Woerle, H. -J.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2013, 67 (12) : 1283 - 1293
  • [10] Comparison of glimepiride & gliclazide in metformin-treated patients with type 2 diabetes: a double-blind, crossover study of vascular function.
    Davis, K
    Dhindsa, P
    Holt, M
    Donnelly, R
    DIABETOLOGIA, 2001, 44 : A234 - A234
12345